Diagnosis and management of paroxysmal nocturnal hemoglobinuria
about
Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuriaEculizumab for treating patients with paroxysmal nocturnal hemoglobinuriaHow I treat paroxysmal nocturnal hemoglobinuriaBiosynthesis and deficiencies of glycosylphosphatidylinositolPesg PNH diagnosis, follow-up and treatment guidelinesUsing functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancerReview article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.Stochastic dynamics and the evolution of mutations in stem cellsThe management of Cesarean delivery in a parturient with paroxysmal nocturnal hemoglobinuria complicated by severe preeclampsia.A case of paroxysmal nocturnal hemoglobinuria presenting with intra-abdominal bleeding due to splenic rupture, developing renal infarct.Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience.Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.Paroxysmal nocturnal hemoglobinuria in pediatric patients.Predictors of hemoglobin response to eculizumab therapy in paroxysmal nocturnal hemoglobinuria.Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure.Paroxysmal nocturnal haemoglobinuria. Experience over a 10 years period.Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia.Flow cytometry screening for paroxysmal nocturnal hemoglobinuria: A single-center experience in Saudi Arabia.Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal HemoglobinuriaHypomegakaryocytic thrombocytopenia (HMT): an immune-mediated bone marrow failure characterized by an increased number of PNH-phenotype cells and high plasma thrombopoietin levels.Paroxysmal Nocturnal Hemoglobinuria in the Differential Diagnosis of Thrombocytopenia.Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry.A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC modelParoxysmal nocturnal hemoglobinuria with copy number-neutral 6pLOH in GPI (+) but not in GPI (-) granulocytesThe challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failureHematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.Automated analysis of GPI-deficient leukocyte flow cytometric data using GemStone™.Dose-dependent regulation of primitive erythroid maturation and identity by the transcription factor EklfDeep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria.Paroxysmal nocturnal hemoglobinuriaSimple monitoring of gene targeting efficiency in human somatic cell lines using the PIGA gene.Hemoglobinuria misidentified as hematuria: review of discolored urine and paroxysmal nocturnal hemoglobinuria.Clinical management of paroxysmal nocturnal haemoglobinuria in pregnancy: three case reports.The use of the complement inhibitor eculizumab (Soliris®) for treating Korean patients with paroxysmal nocturnal hemoglobinuria.Paroxysmal nocturnal hemoglobinuria: a single Spanish center's experience over the last 40 yrMolecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuriaSafety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial.
P2860
Q24193045-34C47B97-F29C-4212-B04A-76027553DDC3Q24201126-431A8170-3B29-449C-A890-E01B081C00D7Q24648538-95276774-4D1A-47A0-ADA6-1B16EA911A34Q26998348-7439DB89-6329-43C3-8401-915E266A26FBQ27021868-7C37CF35-552A-4EED-B8D4-611086A16682Q28480572-A5C5C881-4593-4B4F-8CAC-217C9425E3D2Q30244631-987DA330-4AAB-43D4-B63F-C70FE8373CD6Q31017219-1A2634A9-686F-4D93-AC3D-68D802FEBEC8Q33376085-962A4A78-1004-498D-B116-538A722B3111Q33379600-3000B8B3-D456-414B-8542-321D834D5B9DQ33395464-0B7F6B09-40F9-497B-890D-3CBB38BD1803Q33398524-C8CFD869-A9BA-45CF-A1DB-F16BFF296B30Q33398617-8E6A40B6-066F-4589-BA0E-AE0DF20EBB33Q33403710-04B12F9F-BBB7-4C12-9F1E-E3F6FF3099C2Q33405829-188919DA-908C-4C18-B7B7-470771FF3520Q33411290-7024E874-9E91-4B65-8DF9-F7DA4D16D33CQ33424960-E91B9CA0-CF85-49E4-A7DF-EF077FAA3BA8Q33425335-23A21AD0-F008-43A2-A713-A0AD85A475A8Q33426921-36E3FC59-8C12-44FC-9E8A-BDA7DA270F9FQ33433460-B83409C1-B049-448B-8C2F-081BEBAFAD4EQ33441281-7B999D5A-D2C5-4435-A341-60706C4F190CQ33558763-71E38784-AFC5-4C26-BDD4-CCD2C9159DE8Q33602746-D11D533E-99D8-49CA-A0DC-E19A179396B4Q33765341-CA0664BE-81FF-4ABF-B24D-B2AFA56BF247Q33829778-A6402577-8D4D-4272-BD9D-9FC8C36AC3B9Q33886212-FE7F3E32-A761-4BE5-8210-2554A7B1012DQ34148715-8A1449D1-679D-4477-87AC-5CCD19FFE303Q34218827-4AE2A72E-D2B5-4325-8042-2D614ED02D03Q34261235-9624ADB3-140B-4F0A-984A-B3171749CF18Q34310936-A182057A-72ED-4C8E-A168-379A5DBFD330Q34311583-AEEBB51F-DEB2-405C-ACE9-81313945F12AQ34431429-BF2CAFF4-487A-4533-B519-B8B243AC61D4Q34443086-3CA9684E-C567-4332-A64D-697CEB01D3B0Q34462881-94245DB0-B83E-4412-B1E7-E63E7F6DB39BQ34492818-3138BB32-550F-4FC6-8DD1-D28AF885D06EQ34501102-D1308251-8249-415B-9621-B0E497186124Q34516330-2976C2EB-F1E7-4431-B185-1F640F4C4C62Q34561626-74B318F1-2D10-44AE-92A1-AFB411800C6BQ34603645-9311005F-AF56-4FFA-B9C2-3D45A0F43EDDQ34626253-FCB70927-09A2-45EE-84D9-5AE18FDF897E
P2860
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@ast
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@en
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@en-gb
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@nl
type
label
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@ast
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@en
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@en-gb
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@nl
prefLabel
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@ast
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@en
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@en-gb
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@nl
P2093
P2860
P3181
P1433
P1476
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
@en
P2093
Charles Parker
Gerard Socié
Jun-Ichi Nishimura
Mitsuhiro Omine
Monica Bessler
Neal Young
Russell Ware
Stephen Richards
Taroh Kinoshita
Wendell Rosse
P2860
P304
P3181
P356
10.1182/BLOOD-2005-04-1717
P407
P577
2005-12-01T00:00:00Z